Literature DB >> 7760083

Transcranial optical path length in infants by near-infrared phase-shift spectroscopy.

D A Benaron1, C D Kurth, J M Steven, M Delivoria-Papadopoulos, B Chance.   

Abstract

BACKGROUND: Near-infrared spectroscopy (NIRS) is an emerging technique for noninvasive, bedside monitoring of cerebral oxygenation and blood flow. Traditionally, it has relied on the Beer's Law relationship in which the concentration of light-absorbing oxygen-carrying pigments is proportional to their light absorbance, and inversely proportional to an optical path length (a measure of the distance traveled by photons passing through the tissue). In practice, NIRS has been based upon assumptions that mean transcranial optical path length, the average optical path length for a given patient, is constant among patients and independent of the wavelength of light used.
OBJECTIVE: The objective of our study was to measure mean optical transcranial path length in infants as a step in allowing quantitation of cerebral oxygenation.
METHODS: We measured mean transcranial optical path length in 34 infants, aged 1 day to 3 years, using amplitude-modulated phase-shift spectroscopy at 754 nm and 816 nm. Optical transcranial path lengths (mean +/- SEM) were 8.6 +/- 0.9 cm, 11.1 +/- 0.9 cm, and 11.3 +/- 0.9 cm at 754 nm, and 8.8 +/- 0.9 cm, 11.2 +/- 0.8 cm, and 11.1 +/- 0.9 cm at 816 nm, using emitter-detector separations of 1.8, 2.5, and 3.0 cm, respectively. Optical path length increased as emitter-detector separation, head circumference, or age increased. Variance in the ratio of mean optical path lengths at the two different wavelengths exceeded that accounted for by variation in repeated measures alone (p < 0.001), suggesting that optical path length is also not independent of wavelength.
CONCLUSIONS: NIRS instrument emitter-detector geometry, subject age, head size, and wavelength used each influence optical path length. Quantitative NIRS measurements in clinical use may require concurrent measurement of both absorbance and optical path length at each wavelength, or use of newer measures that are not based upon Beer's Law assumptions.

Entities:  

Mesh:

Year:  1995        PMID: 7760083     DOI: 10.1007/BF01617732

Source DB:  PubMed          Journal:  J Clin Monit        ISSN: 0748-1977


  37 in total

1.  The theoretical basis for the determination of optical pathlengths in tissue: temporal and frequency analysis.

Authors:  S R Arridge; M Cope; D T Delpy
Journal:  Phys Med Biol       Date:  1992-07       Impact factor: 3.609

2.  Ballistic 2-d imaging through scattering walls using an ultrafast optical kerr gate.

Authors:  L Wang; P P Ho; C Liu; G Zhang; R R Alfano
Journal:  Science       Date:  1991-08-16       Impact factor: 47.728

3.  Transillumination imaging performance: a time-of-flight imaging system.

Authors:  J C Hebden; R A Kruger
Journal:  Med Phys       Date:  1990 May-Jun       Impact factor: 4.071

4.  Cotside measurement of cerebral blood flow in ill newborn infants by near infrared spectroscopy.

Authors:  A D Edwards; J S Wyatt; C Richardson; D T Delpy; M Cope; E O Reynolds
Journal:  Lancet       Date:  1988-10-01       Impact factor: 79.321

5.  Measurement of optical path length for cerebral near-infrared spectroscopy in newborn infants.

Authors:  J S Wyatt; M Cope; D T Delpy; P van der Zee; S Arridge; A D Edwards; E O Reynolds
Journal:  Dev Neurosci       Date:  1990       Impact factor: 2.984

6.  Estimation of optical pathlength through tissue from direct time of flight measurement.

Authors:  D T Delpy; M Cope; P van der Zee; S Arridge; S Wray; J Wyatt
Journal:  Phys Med Biol       Date:  1988-12       Impact factor: 3.609

7.  A method to estimate the ratio of absorption coefficients of two wavelengths using phase-modulated near infrared light spectroscopy.

Authors:  M Haida; M Miwa; A Shiino; B Chance
Journal:  Anal Biochem       Date:  1993-02-01       Impact factor: 3.365

8.  Wavelength dependence of the differential pathlength factor and the log slope in time-resolved tissue spectroscopy.

Authors:  M Essenpreis; M Cope; C E Elwell; S R Arridge; P van der Zee; D T Delpy
Journal:  Adv Exp Med Biol       Date:  1993       Impact factor: 2.622

9.  Near-infrared optical imaging of tissue phantoms with measurement in the change of optical path lengths.

Authors:  E M Sevick; C L Burch; B Chance
Journal:  Adv Exp Med Biol       Date:  1994       Impact factor: 2.622

10.  Extinction and absorption coefficients and scattering phase functions of human tissues in vitro.

Authors:  R Marchesini; A Bertoni; S Andreola; E Melloni; A E Sichirollo
Journal:  Appl Opt       Date:  1989-06-15       Impact factor: 1.980

View more
  5 in total

Review 1.  Graph analysis of functional brain networks: practical issues in translational neuroscience.

Authors:  Fabrizio De Vico Fallani; Jonas Richiardi; Mario Chavez; Sophie Achard
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-05       Impact factor: 6.237

2.  Comparison of two devices using near-infrared spectroscopy for the measurement of tissue oxygenation during a vascular occlusion test in healthy volunteers (INVOS® vs. InSpectra™).

Authors:  Ji-Hyun Lee; Yong-Hee Park; Hee-Soo Kim; Jin-Tae Kim
Journal:  J Clin Monit Comput       Date:  2014-07-09       Impact factor: 2.502

3.  Continuous correction of differential path length factor in near-infrared spectroscopy.

Authors:  Tanveer Talukdar; Jason H Moore; Solomon G Diamond
Journal:  J Biomed Opt       Date:  2013-05       Impact factor: 3.170

4.  A portable near infrared spectroscopy system for bedside monitoring of newborn brain.

Authors:  Alper Bozkurt; Arye Rosen; Harel Rosen; Banu Onaral
Journal:  Biomed Eng Online       Date:  2005-04-29       Impact factor: 2.819

Review 5.  Functional near-infrared spectroscopy in movement science: a systematic review on cortical activity in postural and walking tasks.

Authors:  Fabian Herold; Patrick Wiegel; Felix Scholkmann; Angelina Thiers; Dennis Hamacher; Lutz Schega
Journal:  Neurophotonics       Date:  2017-08-01       Impact factor: 3.593

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.